Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Albemarle (GB:0HC7)
LSE:0HC7
Albemarle (0HC7) Share Price & Analysis
3 Followers
0HC7 Stock Chart & Stats
Day’s Range$111.19 - $114.62
52-Week Range― - ―
Previous Close$113.55
Volume2.59K
Average Volume (3M)N/A
Market Cap
$13.42B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 01, 2024EPS Estimate
$0.25Last Dividend Ex-Date
Mar 14, 2024Dividend Yield1.4%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$144.32Price Target Upside25.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering20
Albemarle News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAlbemarle's strategic capital increase positions the company to solidify its market leadership and continue its expansion, even in a challenging industry year.
Market GrowthThe bullish sentiment for lithium is reinforced by growing demand for electric vehicles, suggesting a strong outlook for lithium miners.
Stock ValuationAlbemarle's stock is considered undervalued, trading close to trough levels with potential for a significant EBITDA increase in the coming years.
Bears Say
Dividend ConcernsDividend payment on the convertible equity is not tax deductible, effectively a ~10% pre-tax interest payment.
Financial PerformanceValuation adjustments reflect higher interest expense with EPS estimates revised downwards and price target declining to reflect incremental debt.
Stock DilutionThe issuance of preferred equity results in approximately 16% dilution at the current stock price.
---
Options Prices
Currently, No data available
---
Ownership Overview
8.18% Insiders
35.20% Mutual Funds
30.13% Other Institutional Investors
26.50% Public Companies and
Individual Investors
0HC7 FAQ
What was Albemarle’s price range in the past 12 months?
Currently, no data Available
What is Albemarle’s market cap?
Currently, no data Available
When is Albemarle’s upcoming earnings report date?
Albemarle’s upcoming earnings report date is May 01, 2024 which is in 4 days.
How were Albemarle’s earnings last quarter?
Albemarle released its earnings results on Feb 14, 2024. The company reported $1.85 earnings per share for the quarter, beating the consensus estimate of $0.984 by $0.866.
Is Albemarle overvalued?
According to Wall Street analysts Albemarle’s price is currently Undervalued.
Does Albemarle pay dividends?
Albemarle pays a Quarterly dividend of $0.4 which represents an annual dividend yield of 1.4%. See more information on Albemarle dividends here
What is Albemarle’s EPS estimate?
Albemarle’s EPS estimate is $0.25.
How many shares outstanding does Albemarle have?
Currently, no data Available
What happened to Albemarle’s price movement after its last earnings report?
Albemarle reported an EPS of $1.85 in its last earnings report, beating expectations of $0.984. Following the earnings report the stock price went up 6.087%.
Which hedge fund is a major shareholder of Albemarle?
Among the largest hedge funds holding Albemarle’s share is PRIMECAP Management Co. It holds Albemarle’s shares valued at 502M.
---
Albemarle Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$144.32 (25.93% Upside)
$144.32 (25.93% Upside)
Blogger Sentiment
Bullish
GB:0HC7 Sentiment 90%
Sector Average 73%
Sector Average 73%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.26%
12-Months-Change
Fundamentals
Return on Equity
18.09%
Trailing 12-Months
Asset Growth
18.21%
Trailing 12-Months
Company Description
Albemarle
Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.
---
0HC7 Company Deck
---
0HC7 Earnings Call
Q4 2024
0:00 / 0:00
---
0HC7 Net sales Breakdown
73.61% Energy Storage
15.41% Specialties
10.98% Ketjen
---
0HC7 Stock 12 Months Forecast
Average Price Target
$144.32
▲(25.93% Upside)
Technical Analysis
Albemarle
―
Chemours Company
―
Sociedad Quimica Y Minera SA
―
FMC
―
Lithium Americas Corp.
―
Best Analysts Covering 0HC7
1 Year
1 Year Success Rate
10/23 ratings generated profit
1 Year Average Return
+12.26%
reiterated a buy rating 2 months ago
Copying Joel Jackson's trades and holding each position for 1 Year would result in 43.48% of your transactions generating a profit, with an average return of +12.26% per trade.
---